breast cancer
Pfizer to Buy Medivation for $14 Billion
Pfizer to Buy Medivation for $14 Billion
Bob Grant | Aug 22, 2016
The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.
Esteemed Cancer Surgeon Dies
Esteemed Cancer Surgeon Dies
Amanda B. Keener | Aug 12, 2015
Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.
BRCA Breakthroughs?
BRCA Breakthroughs?
Jenny Rood | Apr 21, 2015
Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.
NCI: Breast Cancer Cases Could Rise by 50 Percent
NCI: Breast Cancer Cases Could Rise by 50 Percent
Bob Grant | Apr 21, 2015
A National Cancer Institute model forecasts a marked increase in estrogen receptor-positive tumors among older women by 2030.
<em>BRCA</em> Mutations Mapped
BRCA Mutations Mapped
Tracy Vence | Apr 8, 2015
In a large study, researchers find evidence to suggest that the type and location of a woman’s BRCA1/2 mutations may affect her cancer risk.
Three Retractions for Highly Cited Author
Three Retractions for Highly Cited Author
Kerry Grens | Mar 19, 2015
Robert Weinberg’s team at MIT is pulling three papers, noting some figure panels were composites of different experiments.
Reduced Risk?
Reduced Risk?
Molly Sharlach | Oct 22, 2014
A genome-wide association study identifies a SNP that could help explain the relatively low rates of breast cancer among Latina women.
Light’s Dark Side
Light’s Dark Side
Kate Yandell | Jul 25, 2014
Exposure to dim light at night speeds the growth of human breast cancer tumors implanted into rats and makes the cancer resistant to the drug tamoxifen.
A Multi-Cancer Diagnostic?
A Multi-Cancer Diagnostic?
Kate Yandell | Jul 14, 2014
Researchers report an ability to detect several types of cancer in blood samples based on signatures of immune response, but some are skeptical about the utility of such a test.
Cancer Research ROI
Cancer Research ROI
Rina Shaikh-Lesko | Jun 16, 2014
Report quantifies the returns from the U.K.’s investments in oncology.